Fichas
Enoxaparin sodium
Fichas del conjunto (13)
- 1Therapeutic classAnticoagulant
- 2Pharmaceutical classLow molecular weight heparin
- 3Indications- Prevention of VTE in surgical or bed-bound med patients
- treatment for DVT and PE
- Treatment of acute STEMI and non-STEMI as well as unstable angina - 4ActionInactivates clotting factors thrombonin and Xa by binding to antithrombonin III
- 5AbsorptionWell-absorbed subcut
- 6DistributionDoes not cross the placenta or enter breast milk
- 7Metabolism & excretionMetabolised by the liver and excreted by the kidneys in urine
- 8Half-life4.5 hrs
- 9Contraindications/precautions- caution in renally impaired
- Hepatic impairment
- Elderly may require dose adjustment
- Those at risk of bleeding - 10Adverse reactionsCVS: brusing and bleeding CNS: pain at the inject. site May cause hyperkalemia, HAEMO: can cause irreversible thrombocytopenia
- 11InteractionsWhen used in conjunction with other anticoagulants can increase potency
- 12Nursing assessment implications- Liver & renal function
- Electrolyte balance
- Post administration clotting factor blood tests - 13EducationAsk patient to advise if they notice any unexplained bleeding or bruising
May require self-admin education if prolonged post-discharge use is required
Información
- Descripción
- El usuario ha eliminado su información de asignaturas Fichas sobre Enoxaparin sodium, creado por Usuario eliminado el 04/06/2018.
- Creado por
- Usuario eliminado · jun 2018
- Actualizado
- 4 jun 2018
- Visitas
- 11
- Historial
-
- Creado por Em J · 4 jun 2018
- Copiado por Em J · 4 jun 2018
- Valoración